Generated Narrative: Composition 568057
version: 2; Last updated: 2026-05-30 15:48:01+0000
Profile: M11ReportContainer
ArtifactPublicationStatus: Active
url: https://fevir.net/resources/Composition/568057
identifier: FEvIR Object Identifier/568057
status: Final
type: CeSHarP Report
date: 2026-05-30 15:48:01+0000
author: Brian S. Alper, MD, MSPH
title: M11 Report for M11ResearchStudy Template
custodian: Computable Publishing LLC
relatesTo
type: Derived From
target: M11ResearchStudy Template
relatesTo
type: Cite As
target:
M11 Report for M11ResearchStudy Template [Database Entry: FHIR Composition Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 568057. Revised 2026-05-30. Available at: https://fevir.net/resources/Composition/568057. Computable resource at: https://fevir.net/resources/Composition/568057#json.
\n
| Full Title: | M11ResearchStudy Template |
| Sponsor Protocol Identifier: | [Replace with a unique alphanumeric identifier for the trial, designated by the sponsor.] |
| Original Protocol: | [Original Protocol Indicator] |
| Version Number: | [For use by the sponsor at their discretion.] |
| Version Date: | [For use by the sponsor at their discretion.] |
| Sponsor’s Investigational Product Code(s): | [Enter the sponsor’s unique identifier for investigational product(s) in the trial.Add fields as needed.] |
| Investigational Product Name(s): | [Omit nonproprietary name field if a nonproprietary name has not yet been assigned. Omit proprietary name field if not yet established.] |
| Trial Phase: | [For trials combining investigational drugs or vaccines with devices, classify according to the phase of drug development.] |
| Sponsor Name and Address: | [Enter Sponsor Name.] [Enter Sponsor Legal Address.] [Add headings and lines for each Co-Sponsor Name and Address: and Local Sponsor Name and Address: if needed.] |
| Device Manufacturer Name and Address: | [Manufacturer name and address information is required only for drug / device combination protocols that include investigational device(s) and should not be included for other protocols.Include the manufacturer address only if the manufacturer is different than the sponsor listed above. Add additional fields as needed if multiple investigational devices will be used in the trial or if there are multiple manufacturers for a single device. Delete this line if not applicable.] |
| Regulatory or Clinical Trial Identifier(s): | FOI 568025 identifier [To be replaced] assigned by [To be replaced] |
| Sponsor Approval: | [Enter Sponsor Approval Date or State location where sponsor approval information can be found] |
Sponsor Signatory: [Enter sponsor signatory (e.g., name, title, signature and date, or tate location where sponsor signatory information can be found (e.g., electronic signature)]
Medical Expert Contact: [Enter Medical Expert contact information(as designated by sponsor, or State location where Medical Expert contact information can be found]
Amendment Details [For an original protocol that has not been amended, state { This protocol has not been amended.} Otherwise state { This is the first protocol amendment.} Or { This protocol has been amended previously. Details of prior amendments are presented in Section 12.3 Prior Protocol Amendment(s).}]